Serotonin-related

32 combinations in this group

MAO — Monoamine oxidase

MAO — monoamine oxidase

An enzyme involved in breaking down serotonin.

Breakdown and reuptake are different processes.

Sources: MAO — monoamine oxidase

Monoamine oxidase inhibition; MAO-A activity is particularly relevant to serotonin toxicity

Definition row

Combinations with MAO

SERT — Serotonin reuptake

SERT

A transporter protein involved in serotonin reuptake.

Inhibiting transport differs from acting on receptors.

Sources: SERT

Serotonin reuptake inhibition

Definition row

Combinations with SERT

REL — Monoamine release

Neurotransmitter release

Movement of neurotransmitter molecules from a nerve ending into the space between cells.

During release a neurotransmitter leaves a nerve ending; during reuptake it returns into a cell.

Sources: Neurotransmitter release

Monoamine release, with serotonergic contribution where indicated

Definition row

Combinations with REL

5HT-R — Serotonin receptors

Receptor

A protein that binds particular molecules and participates in a cell response.

Different receptors have different functions.

Sources: Receptor

Serotonin receptor effects; does not mean the same mechanism as release or SERT inhibition

Definition row

Combinations with 5HT-R

How these processes differ

Serotonin processes

Qualitative illustration: highlights do not measure concentration, effect strength or danger.

  • Release

    Monoamine release, with serotonergic contribution where indicated

  • Reuptake

    Serotonin reuptake inhibition

  • MAO metabolism

    Monoamine oxidase inhibition; MAO-A activity is particularly relevant to serotonin toxicity

  • Receptor action

    Serotonin receptor effects; does not mean the same mechanism as release or SERT inhibition

Reference view

For serotonin toxicity, an especially important pattern is increased serotonin release or reduced reuptake together with inhibition of serotonin breakdown through MAO. Many psychedelics act through 5-HT2A agonism, while MDMA increases serotonin release. Interaction concerns depend on each substance’s specific mechanism [8, 9].

Reference view of the four processes. Choose an example to read its source explanation. Highlighting marks the selected process.

LSD / psilocybin / psilocin

With psychological effects given relatively little weight, LSD and psilocybin rank below MDMA and MAOIs. These groups differ in the serotonin-elevating mechanisms underlying the assessment [8].

MDMA

A controlled study involved 15 healthy men. They took MDMA by mouth, followed by DXM as a metabolic probe. DXM Cmax and AUC increased approximately tenfold, while DXO measures decreased [3].

The abstract reports CYP2D6 recovery after approximately 10 days and a recovery half-life of 46.6 hours. The full text estimates that half-life by fitting a monoexponential model to a urinary metabolic-ratio marker. At the 10-day observation, the Results and Discussion describe a remaining departure of the marker from baseline and limitations of the recovery models [3].

These findings describe pharmacokinetics and enzyme-probe measurements. The fold change can differ at other doses because of metabolic saturation and exposure-dependent inhibition. The study did not measure poisoning rates during combined recreational use or establish an individual safe waiting interval.

The authors note that the estimate appears to underestimate the time to recovery. They question the validity of a longer biphasic-model estimate because of variability in the data and insufficient data points over time [3].

MAO inhibition

Reference view
Reference

Open the source and related combinations →